Direct Oral Anticoagulant Market Report

Global and Region Direct Oral Anticoagulant Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：147
  • REPORT CODE：GMM896816
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Direct Oral Anticoagulant market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Direct Oral Anticoagulantmarket, defines the market attractiveness level of Direct Oral Anticoagulant market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Direct Oral Anticoagulant industry, describes the types of Direct Oral Anticoagulant market, the applications of major players and the market size, and deeply analyzes the current situation of the global Direct Oral Anticoagulant market and the development prospects and opportunities of Direct Oral Anticoagulant industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Direct Oral Anticoagulant market in Chapter 13.

    By Player:

    • Teva Pharmaceutical Industries Ltd

    • Bristol-Meyers Squibb Co

    • Bayer AG

    • Daiichi Sankyo Company, Limited

    • Boehringer Ingelheim Pharmaceuticals, Inc

    • Pab Organics Private Limited

    By Type:

    • Apixaban

    • Dabigatran

    • Rivaroxaban

    • Edoxaban

    By End-User:

    • Hospitals Pharmacies

    • Drug Stores

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Direct Oral Anticoagulant Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Direct Oral Anticoagulant Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Direct Oral Anticoagulant Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Direct Oral Anticoagulant Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Direct Oral Anticoagulant Market Analysis and Outlook to 2022

    • 7.1 Global Direct Oral Anticoagulant Consumption (2017-2022)

    • 7.2 United States Direct Oral Anticoagulant Consumption (2017-2022)

    • 7.3 Europe Direct Oral Anticoagulant Consumption (2017-2022)

    • 7.4 China Direct Oral Anticoagulant Consumption (2017-2022)

    • 7.5 Japan Direct Oral Anticoagulant Consumption (2017-2022)

    • 7.6 India Direct Oral Anticoagulant Consumption (2017-2022)

    • 7.7 South Korea Direct Oral Anticoagulant Consumption (2017-2022)

    8 Region and Country-wise Direct Oral Anticoagulant Market Analysis and Outlook to 2028

    • 8.1 Global Direct Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.2 United States Direct Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.3 Europe Direct Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.4 China Direct Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.5 Japan Direct Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.6 India Direct Oral Anticoagulant Consumption Forecast (2022-2028)

    • 8.7 South Korea Direct Oral Anticoagulant Consumption Forecast (2022-2028)

    9 Global Direct Oral Anticoagulant Market Outlook by Types and Applications to 2022

    • 9.1 Global Direct Oral Anticoagulant Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Apixaban Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Dabigatran Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Rivaroxaban Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Edoxaban Consumption and Growth Rate (2017-2022)

    • 9.2 Global Direct Oral Anticoagulant Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Drug Stores Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Direct Oral Anticoagulant Market Outlook by Types and Applications to 2028

    • 10.1 Global Direct Oral Anticoagulant Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Apixaban Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Dabigatran Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Rivaroxaban Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Edoxaban Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Direct Oral Anticoagulant Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Direct Oral Anticoagulant Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Direct Oral Anticoagulant Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Direct Oral Anticoagulant Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Direct Oral Anticoagulant Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Direct Oral Anticoagulant Market Competitive Analysis

    • 14.1 Teva Pharmaceutical Industries Ltd

      • 14.1.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.1.2 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product and Service

    • 14.2 Bristol-Meyers Squibb Co

      • 14.2.1 Bristol-Meyers Squibb Co Company Details

      • 14.2.2 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product and Service

    • 14.3 Bayer AG

      • 14.3.1 Bayer AG Company Details

      • 14.3.2 Bayer AG Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer AG Direct Oral Anticoagulant Product and Service

    • 14.4 Daiichi Sankyo Company, Limited

      • 14.4.1 Daiichi Sankyo Company, Limited Company Details

      • 14.4.2 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product and Service

    • 14.5 Boehringer Ingelheim Pharmaceuticals, Inc

      • 14.5.1 Boehringer Ingelheim Pharmaceuticals, Inc Company Details

      • 14.5.2 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product and Service

    • 14.6 Pab Organics Private Limited

      • 14.6.1 Pab Organics Private Limited Company Details

      • 14.6.2 Pab Organics Private Limited Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pab Organics Private Limited Direct Oral Anticoagulant Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Direct Oral Anticoagulant

    • Figure Direct Oral Anticoagulant Picture

    • Table Global Direct Oral Anticoagulant Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Direct Oral Anticoagulant Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Direct Oral Anticoagulant Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Direct Oral Anticoagulant Consumption by Country (2017-2022)

    • Figure United States Direct Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Table Europe Direct Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Figure China Direct Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Figure Japan Direct Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Figure India Direct Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Figure South Korea Direct Oral Anticoagulant Consumption and Growth Rate (2017-2022)

    • Figure Global Direct Oral Anticoagulant Consumption Forecast by Country (2022-2028)

    • Figure United States Direct Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Direct Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Direct Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Direct Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Direct Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Direct Oral Anticoagulant Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Apixaban Consumption and Growth Rate (2017-2022)

    • Figure Global Dabigatran Consumption and Growth Rate (2017-2022)

    • Figure Global Rivaroxaban Consumption and Growth Rate (2017-2022)

    • Figure Global Edoxaban Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Apixaban Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Dabigatran Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Rivaroxaban Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Edoxaban Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Direct Oral Anticoagulant Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Direct Oral Anticoagulant Export by Region (Top 5 Countries) (2017-2028)

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Direct Oral Anticoagulant Product and Service

    • Table Bristol-Meyers Squibb Co (Foundation Year, Company Profile and etc.)

    • Table Bristol-Meyers Squibb Co Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Meyers Squibb Co Direct Oral Anticoagulant Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Direct Oral Anticoagulant Product and Service

    • Table Daiichi Sankyo Company, Limited (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Company, Limited Direct Oral Anticoagulant Product and Service

    • Table Boehringer Ingelheim Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Pharmaceuticals, Inc Direct Oral Anticoagulant Product and Service

    • Table Pab Organics Private Limited (Foundation Year, Company Profile and etc.)

    • Table Pab Organics Private Limited Direct Oral Anticoagulant Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pab Organics Private Limited Direct Oral Anticoagulant Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US